Your browser doesn't support javascript.
loading
CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival.
Yogev, Nir; Bedke, Tanja; Kobayashi, Yasushi; Brockmann, Leonie; Lukas, Dominika; Regen, Tommy; Croxford, Andrew L; Nikolav, Alexei; Hövelmeyer, Nadine; von Stebut, Esther; Prinz, Marco; Ubeda, Carles; Maloy, Kevin J; Gagliani, Nicola; Flavell, Richard A; Waisman, Ari; Huber, Samuel.
Afiliação
  • Yogev N; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Department of Dermatology and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital of Cologne, 50937 Cologne, Germany. Electronic
  • Bedke T; Hamburg Center for Translational Immunology (HCTI) and Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Kobayashi Y; Department of Immunobiology, School of Medicine, Yale University, New Haven, CT 06520, USA.
  • Brockmann L; Hamburg Center for Translational Immunology (HCTI) and Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Lukas D; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Department of Dermatology and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital of Cologne, 50937 Cologne, Germany.
  • Regen T; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Croxford AL; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Nikolav A; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Hövelmeyer N; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • von Stebut E; Department of Dermatology and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital of Cologne, 50937 Cologne, Germany.
  • Prinz M; Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
  • Ubeda C; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.
  • Maloy KJ; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Gagliani N; Hamburg Center for Translational Immunology (HCTI) and Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Department of General, Visceral and Thoracic Surgery, University Medical Cent
  • Flavell RA; Department of Immunobiology, School of Medicine, Yale University, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Waisman A; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Focus Program Translational Neurosciences, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Research Center for Immunotherapy, University Medic
  • Huber S; Hamburg Center for Translational Immunology (HCTI) and Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany. Electronic address: shuber@uke.de.
Cell Rep ; 38(13): 110565, 2022 03 29.
Article em En | MEDLINE | ID: mdl-35354043
ABSTRACT
Interleukin (IL)-10 is considered a prototypical anti-inflammatory cytokine, significantly contributing to the maintenance and reestablishment of immune homeostasis. Accordingly, it has been shown in the intestine that IL-10 produced by Tregs can act on effector T cells, thereby limiting inflammation. Herein, we investigate whether this role also applies to IL-10 produced by T cells during central nervous system (CNS) inflammation. During neuroinflammation, both CNS-resident and -infiltrating cells produce IL-10; yet, as IL-10 has a pleotropic function, the exact contribution of the different cellular sources is not fully understood. We find that T-cell-derived IL-10, but not other relevant IL-10 sources, can promote inflammation in experimental autoimmune encephalomyelitis. Furthermore, in the CNS, T-cell-derived IL-10 acts on effector T cells, promoting their survival and thereby enhancing inflammation and CNS autoimmunity. Our data indicate a pro-inflammatory role of T-cell-derived IL-10 in the CNS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Interleucina-10 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Interleucina-10 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article